Results 11 to 20 of about 1,095,480 (156)
Nephrogenic systemic fibrosis: A brief review [PDF]
Indian Journal of Dermatology, 2011 Nephrogenic systemic fibrosis is a fibrosing disorder of the skin that develops in patients with advanced renal failure. It mostly presents with progressive hardening or induration of the skin of the extremities.
Rajesh Waikhom, Abhijit Taraphder
doaj +5 more sources
Nephrogenic systemic fibrosis: Current concepts [PDF]
Indian Journal of Dermatology, 2011 Nephrogenic systemic fibrosis (NSF) was first described in 2000 as a scleromyxedema-like illness in patients on chronic hemodialysis. The relationship between NSF and gadolinium contrast during magnetic resonance imaging was postulated in 2006, and ...
Prasanta Basak, Stephen Jesmajian
doaj +4 more sources
Nephrogenic systemic fibrosis: Time for the requiem? [PDF]
Indian Journal of Dermatology, 2011 Saumya Panda
doaj +4 more sources
Nefrogén szisztémás fibrosis = Nephrogenic systemic fibrosis
Orvosi Hetilap, 2007 A nefrogén szisztémás fibrosis, melyet korábban nefrogén fibrotizáló dermopathiaként említett az irodalom, egy ritka kórkép, mely vesebetegeknél jelentkezik.
Vágási, Katalin +3 more
core +3 more sources
Nephrogenic systemic fibrosis: epidemiology update
Current Opinion in Internal Medicine, 2008 Purpose of review The aim of this article is to outline the history of nephrogenic systemic fibrosis, a new and serious disease of patients with renal failure, and to give an update on its aetiology and prevalence.
Marckmann, P., Marckmann, Peter
core +5 more sources
Gadolinium and nephrogenic systemic fibrosis [PDF]
Kidney International, 2007 Nephrogenic systemic fibrosis (NSF) is characterized by red skin areas or plaques that over several weeks successively develop to painful thickened skin with a ‘woody’ texture, resembling ‘peau d’orange’. Starting at the extremities, it may spread to the
Prischl, F.C., Grobner, T.
core +4 more sources
Nephrogenic Systemic Fibrosis Risk and Liver Disease [PDF]
International Journal of Nephrology, 2014 Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis,
Robert F. Hanna +6 more
doaj +2 more sources
Sodium thiosulfate for treatment of nephrogenic systemic fibrosis with metastatic pulmonary calcification in a patient undergoing peritoneal dialysis: a case report [PDF]
BMC NephrologyNephrogenic systemic fibrosis (NSF) is a rare systemic disease characterized by widespread, progressive fibrosis of the skin and connective tissue. We report a rare case of NSF and metastatic pulmonary calcification coexisting in a patient undergoing ...
Qiqi Yan +6 more
doaj +2 more sources
Update on nephrogenic systemic fibrosis
Magnetic Resonance Imaging Clinics of North America, 2008 Gadolinium-based contrast agents were for many years considered safe, but this is no longer the case. The least stable agents may trigger the development of nephrogenic systemic fibrosis (NSF), a generalized fibrotic disorder, in renal failure patients ...
Logager, V.B. +2 more
core +5 more sources
Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media [PDF]
South African Journal of Radiology, 2013 Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis.
P.S. Ngoya, Z Vawda, J.W Lotz
doaj +2 more sources